Pharma companies are contributing to the fight against COVID-19 on multiple fronts COVID-19 has thrust the global life sciences industry centre stage.
The sector is playing a key role, through its science, resources and scale, and dedicating huge efforts to develop diagnostics, treatments and vaccines. Around the globe, there are currently around 1,500 industry and academic clinical trials into COVID-19, of which more than 800 are treatment interventions.
Actions of the 20 largest pharma companies
Each of the 20 largest global pharma companies by revenue are contributing to the fight against COVID-19 in one or more ways. Since the beginning of the year, these companies have released 109 announcements about their ongoing responses to the outbreak.